The SCN9A gene helps pain-sensing nerves send electrical signals, so it plays a key role in how you feel pain and, to a lesser extent, smell. If it does not work properly, some people feel little or no pain, while others develop repeated episodes of burning, stabbing, or intense pain. The protein made by this gene helps nerve cells pass along those signals. Variants in the SCN9A gene are best known for causing rare inherited pain conditions.
What is a gene?
A gene is a piece of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for building proteins, which are the parts of cells that do much of the work. Others are mainly involved in controlling when certain processes happen, where they happen, and how strongly they take place. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. For a more in-depth look at this topic, you can find additional information in LearnHub.
Overview
SCN9AGene function
What if the gene works
The SCN9A gene helps nerves that sense pain send electrical signals. This supports normal responses to pain, heat, and smell.
Risk
What if the gene does not work
Depending on the variant, changes in the SCN9A gene can cause either little pain sensing or episodes of burning pain. Milder and more severe variants can influence when symptoms begin, how intense they are, and whether nerve symptoms appear.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided by a pathogenic variant in the SCN9A gene in routine clinical guidelines. The SCN9A gene is widely studied as a pain medicine target, but this has not yet led to a standard gene directed treatment.
Conditions associated with SCN9A
Gene function
What if the gene works
When you touch something hot or feel a pinprick, your nerves need a fast way to carry that message. The SCN9A gene helps make Nav1.7, a channel that lets nerve cells start electrical signals. This is a key part of how the SCN9A gene helps pain signals begin and move through the body.
Nav1.7 helps certain pain-sensing nerves fire when they detect heat, pressure, or injury. This gives your body an early warning system so you can react and protect yourself.
This channel helps small nerve inputs build into a clearer message. In this way, the SCN9A gene supports normal pain signaling from the body to the spinal cord and brain.
Some sensory nerves use Nav1.7 when picking up changes in temperature. That helps everyday sensations like warmth from a mug or the sting of cold air register normally.
Nav1.7 is also active in smell-related nerve cells inside the nose. It helps these cells send scent information onward so the brain can recognize odors.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help explain normal differences among people, such as appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SCN9A gene change the Nav1.7 sodium channel, a tiny gate that helps pain-sensing nerve cells fire. Briefly, how SCN9A variants affect nerve sodium channels depends on the change: some make the channel open too easily or stay active too long, while others reduce activity or keep it from reaching the cell surface. Milder variants may shift signaling slightly. More disruptive variants can cause earlier or stronger pain syndromes, or in loss-of-function cases, little to no pain sensation.
How variants are linked to conditions
The link between SCN9A gene variants and inherited pain conditions is well established. Pathogenic variants in the SCN9A gene can cause inherited erythromelalgia, paroxysmal extreme pain disorder, or congenital insensitivity to pain, depending on the specific variant. Some variants have also been associated with small fiber neuropathy. Symptoms can differ from one person to another, even within the same family.
A variant is not necessarily a diagnosis
Variants in genes are a normal feature of human biology and are widely seen in the general population. Most do not directly affect health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a part. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce risk related to the SCN9A gene. The health effects of SCN9A changes depend mostly on the exact variant, and some triggers such as heat, exercise, or illness can affect symptoms in certain pain conditions rather than changing whether the condition is inherited.
Inheritance of SCN9A variants
SCN9A-related conditions can be inherited in different ways, so how SCN9A variants are inherited depends on the specific condition and variant involved. Some SCN9A-related pain conditions follow an autosomal dominant pattern, which means a parent carrying the variant can pass it to each child with a 50% chance. Other SCN9A-related conditions, including congenital insensitivity to pain, follow an autosomal recessive pattern, which means a child usually inherits one variant from each parent. Sons and daughters are affected similarly because the SCN9A gene is on chromosome 2.
What does my SCN9A result mean for my family?
SCN9A results can mean different things for relatives because this gene is linked to more than one inherited pain condition. In some families, a changed SCN9A copy can run from parent to child, so close relatives may also carry it and may have pain symptoms. In other families, the condition appears only when both copies are changed, which can mean parents are healthy carriers and brothers or sisters could also be affected or be carriers. The family impact depends on the exact SCN9A result and the condition involved.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for SCN9A variants uses a blood sample or cheek swab to look for changes in the SCN9A gene. A lab reads the DNA sequence and compares it with a reference sequence to identify variants, then classifies each finding as disease-causing, likely benign, or uncertain.
When should I consider getting a genetic test?
Genetic testing for the SCN9A gene may be worth considering if someone has unusual inherited pain symptoms, such as repeated burning attacks in the hands or feet, severe brief pain episodes starting early in life, or an inability to feel pain. It can also help when these patterns run in a family.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals varies by the condition and by the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people process a drug more slowly or more quickly, while others have small differences in the body parts that a medicine acts on. This helps explain why the same treatment may work well for one person, seem less helpful for another, or cause stronger side effects in someone else. These differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medication. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support more informed, individualized treatment decisions. If you want to explore this topic further, more information is available in the LearnHub.
Drugs influenced by the SCN9A gene
When should I seek medical advice?
This gene is not currently used in a broadly confirmed way to guide medicine choice or dose, so medication questions are best discussed with your doctor. Research on SCN9A has looked at pain medicines because the gene helps control pain signaling, but this has not led to standard treatment recommendations.
History
Interest in the SCN9A gene grew when families with strikingly different pain experiences helped researchers trace those patterns to a single gene. In the early 2000s, studies linked SCN9A variants to inherited erythromelalgia, a condition marked by episodes of burning pain, and soon after to congenital insensitivity to pain, where people are born unable to feel pain normally. These discoveries drew wide attention because they connected rare family conditions to the biology of pain itself. From these first observations, research expanded steadily. SCN9A became an important landmark in pain genetics and helped shape the search for new pain treatments. Over time, scientists recognized that variants in this gene can contribute to a spectrum of pain related conditions rather than one single picture.